Agrup G, Falck B, Jacobsson S, Rorsman H, Rosengren AM, Rosengren E (1974) 5-S-Cysteinyldopa in melanomas of caucasians. Acta Derm Venereol (Stockholm) 54: 21–23

Article  CAS  Google Scholar 

Agrup G, Edholm L-E, Rorsman H, Rosengren E (1983) Diastereomers of 5-S-cysteinyl-DOPA. Acta Derm Venereol (Stockholm) 63: 59–61

Article  CAS  Google Scholar 

Ambani LM, Melvin H, van Woert MH, Murphy S (1975) Brain peroxidase and catalase in Parkinson's disease. Arch Neurol 32: 114–118

Article  CAS  PubMed  Google Scholar 

Anton AH, Sayre DF (1962) A study of the factors affecting the aluminium oxidetrihydroxyindole procedure for the analysis of catecholamines. J Pharmacol Exp Ther 138: 360–375

Article  CAS  PubMed  Google Scholar 

Cohen G (1983) The pathobiology of Parkinson's disease: biochemical aspects of dopamine neuron senescence. J Neural Transm 19 [Suppl]: 89–103

CAS  Google Scholar 

Dahlqvist I, Falck B, Jacobsson S, Rorsman H, Rosengren AM, Rosengren E (1972) 5-S-Cysteinyldopa in the urine of melanoma patients. Communications from the Department of Anatomy, University of Lund, Sweden, No. 7

Google Scholar 

Das KC, Abramson MB, Katzman R (1978) Neuronal pigments: spectroscopic characterization of human brain melanin. J Neurochem 30: 601–605

Article  CAS  PubMed  Google Scholar 

Dexter DT, Carter C, Agid F, Agid Y, Lees AJ, Jenner P, Mardsen CD (1986) Lipid peroxidation as cause of nigral cell death in Parkinson's disease. Lancet ii: 639–640

Article  Google Scholar 

Dexter DT, Wells FR, Agid F, Agid Y, Lees AJ, Jenner P, Mardsen CD (1987) Increased nigral iron content in post mortem parkinsonian brain. Lancet ii: 1219–1220

Article  Google Scholar 

Fehling C, Hansson C, Poulsen J, Rorsman H, Rosengren E (1981) 5-S-Cysteinyldopa in ganglion stellatum. J Neural Transm 52: 251–257

Article  CAS  PubMed  Google Scholar 

Fornstedt B, Rosengren E, Carlsson A (1986) Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species. Neuropharmacology 25: 451–454

Article  CAS  PubMed  Google Scholar 

Fornstedt B, Carlsson A (1989) A marked rise in 5-S-cysteinyl-dopamine levels in guineapig striatum following reserpine treatment. J Neural Transm 76: 155–161

Article  CAS  PubMed  Google Scholar 

Graham DG (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol Pharmacol 14: 633–643

Article  CAS  PubMed  Google Scholar 

Graham DG, Tiffany SM, Bell WRJr, Gutknecht WF (1978) Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine and related compounds toward C 1300 neuroblastoma cells in vitro. Mol Pharmacol 14: 644–653

Article  CAS  PubMed  Google Scholar 

Ito S, Novellino E, Chiocarra F, Misuraca O, Prota G (1980) Co-polymerization of dopa and cysteinyldopa in melanogenesis in vitro. Experientia 36: 822–823

Article  CAS  PubMed  Google Scholar 

Ito S, Fujita K, Yoshioka M, Sienko D, Nagatsu T (1986) Identification of 5-S- and 2-S-cysteinyldopamine and 5-C-glutathionyldopamine formed from dopamine by highperformance liquid chromatography with electrochemical detection. J Chromatogr 375: 134–140

Article  CAS  Google Scholar 

Kish SJ, Shannak K, Hornykiewicz O (1988) Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 318: 876–880

Article  CAS  PubMed  Google Scholar 

Milliken GA, Johnson DE (1984) Analyses of messy data. Lifetime Learning Publications, Belmont, California, U.S.A.

Google Scholar 

Moldéus P, Nordenskjöld M, Bolcsfoldi G, Eiche A, Haglund U, Lambert B (1983) Genetic toxicity of dopamine. Mutat Res 124: 9–24

Article  PubMed  Google Scholar 

Nordgren L, Rorsman H, Rosengren A-M, Rosengren E (1971) Dopa and dopamine in the pigment of substantia nigra. Experientia 27: 1178–1179

Article  CAS  PubMed  Google Scholar 

Perry TL, Godin DV, Hansen S (1982) Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci Lett 33: 305–310

Article  CAS  PubMed  Google Scholar 

Prota G, Rorsman H, Rosengren AM, Rosengren E (1976) Pheaomelanic pigment from a human melanoma. Experientia 32: 970–971

Article  CAS  PubMed  Google Scholar 

Riederer P, Sofic E, Rausch W-D, Schmidt B, Reynolds GP, Jellinger K, Youdim MBH (1989) Transition metals, ferritin, glutathion and ascorbic acid in parkinsonian brains. J Neurochem 52: 515–520

Article  CAS  PubMed  Google Scholar 

Rodgers AD, Curzon G (1975) Melanin formation by human brain in vitro. J Neurochem 24: 1123–1129

Article  CAS  PubMed  Google Scholar 

Rorsman H, Agrup G, Hansson C, Rosengren AM, Rosengren E (1979) Detection of pheomelanins. In: Klaus SN (ed) Pigment cell, vol 4. Karger, Basel, pp 243–253

Google Scholar 

Rosengren E, Linder-Eliasson E, Carlsson A (1985) Detection of 5-S-cysteinyldopamine in human brain. J Neural Transm 63: 247–253

Article  CAS  PubMed  Google Scholar 

Scheulen M, Wollenberg P, Bolt HM, Kappus H, Remmer H (1975) Irreversible binding of dopa and dopamine metabolites to protein by rat liver microsomes. Biochem Biophys Res Commun 66: 1396–1400

Article  CAS  PubMed  Google Scholar 

Sealy R, Hyde J, Felix C, Menon IA, Prota G (1982) Eumelanins and pheomelanins: characterisation by electron spin resonance. Science 217: 545–547

Article  CAS  PubMed  Google Scholar 

Vogel CL, Dhru Dh, Rorsman H, Rosengren AM, Rosengren E (1974) Dopa and 5-S-cysteinyldopa in malignant melanoma in Ugandan Africans. Acta Derm Venereol (Stockholm) 54: 19–21

Article  CAS  Google Scholar 

Wick MM (1978) Dopamine: a novel antitumor agent active against B-16 melanoma in vivo. J Invest Derm 71: 163–164

Article  CAS  PubMed  Google Scholar 

Wick MM, Byers L, Frei E III (1977) L-Dopa: selective toxicity for melanoma cells in vitro. Science 197: 468–469

Article  CAS  PubMed  Google Scholar 

Wick MM (1980) Levodopa and dopamine analogs as DNA polymerase inhibitors and antitumor agents in human melanoma. Cancer Res 40: 1414–1418

CAS  PubMed  Google Scholar 

Wiesel F-A, Sedvall G (1974) Post-mortal changes of dopamine and homovanillic acid levels in rat striatum as measured by mass fragmentography. Brain Res 65: 547–550

Article  CAS  PubMed  Google Scholar 

Van Woert MH, Prasad KN, Borg DC (1967) Spectroscopic studies of substantia nigra pigment in human subjects. J Neurochem 14: 707–716

Article  PubMed  Google Scholar